Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remimazolam Safety and Efficacy for Nerve Blocks

NCT05415202 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT05415202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remimazolam Safety and Efficacy for Nerve Blocks
Lead sponsor
University of Utah
Phase
Observational
Overall status
Completed
Start date
June 6, 2022
Completion date
August 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

procedural anxiety, procedural pain